ABT
HealthcareAbbott Laboratories
$126.45
+$2.26 (+1.82%)
Jan 5, 2026
Price History (1Y)
Analysis
Abbott Laboratories is a healthcare company operating in the medical devices industry within the broader healthcare sector. With a market capitalization of $220.08 billion and over 114,000 employees, it is a significant player in its field. The company's financial health demonstrates strong profitability, with gross margin at 56.3%, operating margin at 19.4%, and profit margin at 31.9%. Returns on equity (ROE) stand at 30.6%, while returns on assets (ROA) are 6.8%. The balance sheet shows debt of $12.97 billion, offset by cash reserves of $7.73 billion, resulting in a debt-to-equity ratio of 25.31 and a current ratio of 1.70. Abbott Laboratories' valuation context is characterized by a price-earnings (P/E) ratio of 15.59 on trailing twelve months (TTM), increasing to 22.27 for forward earnings. The company's revenue growth rate over the past year is 6.9%, with zero earnings growth (YoY). Dividend yield stands at 203.0%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company provides pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Visit website →Key Statistics
- Market Cap
- $220.08B
- P/E Ratio
- 15.59
- 52-Week High
- $141.23
- 52-Week Low
- $110.86
- Avg Volume
- 6.21M
- Beta
- 0.72
- Dividend Yield
- 203.00%
Company Info
- Industry
- Medical Devices
- Exchange
- NYQ
- Country
- United States
- Employees
- 114,000